Early antibody responses associated with survival in COVID19 patients
Sign Up to like & getrecommendations! Published in 2021 at "PLoS Pathogens"
DOI: 10.1371/journal.ppat.1009766
Abstract: Neutralizing antibodies to the SARS CoV-2 spike proteins have been issued Emergency Use Authorizations and are a likely mechanism of vaccines to prevent COVID-19. However, benefit of treatment with monoclonal antibodies has only been observed… read more here.
Keywords: responses associated; antibodies sars; early antibody; antibody ... See more keywords